# Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

> **NCT01016990** · PHASE2 · UNKNOWN · sponsor: **Auxilio Mutuo Cancer Center** · enrollment: 52 (estimated)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** valproic acid
- **GENETIC:** western blotting
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT01016990
- **Lead sponsor:** Auxilio Mutuo Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016990, "Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01016990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*